Powell, M. A., Hanker, L. C., Ghamande, S., Lindemann, K., Gilbert, L., Oaknin, A., … Nøttrup, T. (2026). PARP inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy. In International Journal of Gynecological Cancer (Vol. 36, pp. 103031–103031). Elsevier BV. https://doi.org/10.1016/j.ijgc.2025.103031

Powell, Matthew A., Lars C. Hanker, Sharad Ghamande, Kristina Lindemann, Lucy Gilbert, Ana Oaknin, Destin Black, et al. “PARP inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.” In International Journal of Gynecological Cancer, 36:103031–103031. Elsevier BV, 2026. https://doi.org/10.1016/j.ijgc.2025.103031.

Powell MA, Hanker LC, Ghamande S, Lindemann K, Gilbert L, Oaknin A, et al. PARP inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy. In: International Journal of Gynecological Cancer. Elsevier BV; 2026. p. 103031–103031.

Powell, Matthew A., et al. “PARP inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.” International Journal of Gynecological Cancer, vol. 36, no. 2, Elsevier BV, 2026, pp. 103031–103031. Crossref, doi:10.1016/j.ijgc.2025.103031.

Powell MA, Hanker LC, Ghamande S, Lindemann K, Gilbert L, Oaknin A, Black D, Savarese A, Secord AA, Kristeleit R, Holloway R, Tromp J, Buscema J, Van Gorp T, Weberpals J, Mavrichev S, Yablonski K, Austin L, Sharma S, Nøttrup T. PARP inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy. International Journal of Gynecological Cancer. Elsevier BV; 2026. p. 103031–103031.